What is MetLife's earnings per share (EPS)?

MetLife (MET) reported diluted earnings per share of $4.71 for fiscal year 2025. This represents a -20.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MetLife Financials

MET

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows MetLife (MET) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 31/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

MetLife has an operating margin of 8.0%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 40/100, indicating healthy but not exceptional operating efficiency. This is down from 8.5% the prior year.

Growth

MetLife's revenue grew 8.6% year-over-year to $77.1B, a solid pace of expansion. This earns a growth score of 48/100.

Leverage

MetLife has elevated debt relative to equity (D/E of 25.22), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Returns

MetLife's ROE of 11.9% shows moderate profitability relative to equity, earning a score of 38/100. This is down from 16.1% the prior year.

Piotroski F-Score Neutral

4/9

MetLife passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

5.06x

For every $1 of reported earnings, MetLife generates $5.06 in operating cash flow ($17.1B OCF vs $3.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

8.5x

MetLife earns $8.5 in operating income for every $1 of interest expense ($6.1B vs $724.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$77.1B

YoY+8.6%

5Y CAGR+2.6%

10Y CAGR+2.3%

MetLife generated $77.1B in revenue in fiscal year 2025. This represents an increase of 8.6% from the prior year.

EBITDA

$6.3B

YoY+2.1%

MetLife's EBITDA was $6.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 2.1% from the prior year.

Net Income

$3.4B

YoY-23.7%

5Y CAGR-9.0%

10Y CAGR-4.5%

MetLife reported $3.4B in net income in fiscal year 2025. This represents a decrease of 23.7% from the prior year.

EPS (Diluted)

$4.71

YoY-20.7%

5Y CAGR-3.7%

10Y CAGR+0.2%

MetLife earned $4.71 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 20.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$22.0B

YoY+9.8%

5Y CAGR+2.2%

10Y CAGR+7.0%

MetLife held $22.0B in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.25

YoY+4.3%

5Y CAGR+4.3%

10Y CAGR+4.3%

MetLife paid $2.25 per share in dividends in fiscal year 2025. This represents an increase of 4.3% from the prior year.

Shares Outstanding

652M

YoY-4.3%

5Y CAGR-5.9%

10Y CAGR-5.1%

MetLife had 652M shares outstanding in fiscal year 2025. This represents a decrease of 4.3% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

8.0%

YoY-0.5pp

MetLife's operating margin was 8.0% in fiscal year 2025, reflecting core business profitability. This is down 0.5 percentage points from the prior year.

Net Margin

4.4%

YoY-1.9pp

5Y CAGR-3.6pp

10Y CAGR-4.4pp

MetLife's net profit margin was 4.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.9 percentage points from the prior year.

Return on Equity

11.9%

YoY-4.2pp

5Y CAGR+4.7pp

10Y CAGR+4.0pp

MetLife's ROE was 11.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.2 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$2.9B

YoY-10.1%

5Y CAGR+20.2%

10Y CAGR+4.1%

MetLife spent $2.9B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 10.1% from the prior year.

Capital Expenditures

N/A

MET Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$77.1B+8.6%	$71.0B+6.1%	$66.9B-2.7%	$68.8B+0.1%	$68.7B+1.3%	$67.8B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$560.0M+16.4%	$481.0M-41.9%	$828.0M+23.8%	$669.0M-0.1%	$670.0M-12.0%	$761.0M
Operating Income	$6.1B+2.4%	$6.0B+4.8%	$5.7B-4.3%	$6.0B	N/A	N/A
Interest Expense	$724.0M-1.9%	$738.0M-0.3%	$740.0M+13.0%	$655.0M+1.2%	$647.0M+2.4%	$632.0M
Income Tax	$1.3B+6.8%	$1.2B+110.4%	$560.0M-47.3%	$1.1B-35.3%	$1.6B+8.8%	$1.5B
Net Income	$3.4B-23.7%	$4.4B+180.5%	$1.6B-70.1%	$5.3B-22.9%	$6.9B+26.8%	$5.4B
EPS (Diluted)	$4.71-20.7%	$5.94+228.2%	$1.81-71.3%	$6.30-17.6%	$7.65+34.7%	$5.68

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$23.8B+37.2%	$17.4B+0.1%	$17.3B-6.6%	$18.6B-0.5%	$18.7B+1.2%	$18.4B+3.5%	$17.8B+11.0%	$16.1B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$186.0M+57.6%	$118.0M-9.2%	$130.0M+3.2%	$126.0M+600.0%	$18.0M-88.9%	$162.0M+5.9%	$153.0M+3.4%	$148.0M
Operating Income	$1.7B+1.8%	$1.6B+18.4%	$1.4B-1.6%	$1.4B-5.1%	$1.5B+3.4%	$1.4B-13.2%	$1.7B+18.6%	$1.4B
Interest Expense	-$74.0M-127.3%	$271.0M+0.7%	$269.0M+4.3%	$258.0M+745.0%	-$40.0M-115.6%	$257.0M0.0%	$257.0M-2.7%	$264.0M
Income Tax	$301.0M-2.3%	$308.0M+25.7%	$245.0M-39.4%	$404.0M+281.1%	$106.0M-83.8%	$653.0M+162.2%	$249.0M+46.5%	$170.0M
Net Income	$809.0M-9.7%	$896.0M+22.9%	$729.0M-22.9%	$945.0M-25.6%	$1.3B-5.3%	$1.3B+41.9%	$946.0M+9.1%	$867.0M
EPS (Diluted)	N/A	$1.22+18.4%	$1.03-19.5%	$1.28	N/A	$1.81+41.4%	$1.28+16.4%	$1.10

MET Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$745.2B+10.0%	$677.5B-1.5%	$687.6B+3.7%	$663.1B-12.7%	$759.7B-4.5%	$795.1B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$22.0B+9.8%	$20.1B-2.8%	$20.6B+2.2%	$20.2B+0.7%	$20.0B+1.3%	$19.8B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$272.0M+14.3%	$238.0M-2.1%	$243.0M+7.5%	$226.0M-3.8%	$235.0M+78.0%	$132.0M
Goodwill	$9.6B+8.0%	$8.9B-3.6%	$9.2B-0.7%	$9.3B-2.5%	$9.5B-5.7%	$10.1B
Total Liabilities	$716.2B+10.2%	$649.8B-1.2%	$657.3B+3.9%	$632.9B-8.5%	$692.0B-3.9%	$720.3B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$28.4B+3.5%	$27.4B-8.6%	$30.0B+0.4%	$29.9B-55.7%	$67.5B-9.5%	$74.6B
Retained Earnings	$44.3B+3.9%	$42.6B+6.2%	$40.1B-0.5%	$40.3B-2.1%	$41.2B+12.9%	$36.5B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$745.2B+3.5%	$719.7B+2.5%	$702.5B+2.1%	$688.3B+1.6%	$677.5B-3.9%	$705.0B+4.3%	$675.7B-0.3%	$677.6B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$22.0B+8.9%	$20.2B-8.8%	$22.2B+4.0%	$21.3B+6.3%	$20.1B-7.8%	$21.8B+4.7%	$20.8B+4.8%	$19.8B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$272.0M-2.9%	$280.0M+5.7%	$265.0M+4.3%	$254.0M+6.7%	$238.0M-2.9%	$245.0M+6.1%	$231.0M-8.0%	$251.0M
Goodwill	$9.6B+5.7%	$9.1B-0.5%	$9.1B+1.2%	$9.0B+1.5%	$8.9B-2.8%	$9.2B+2.3%	$8.9B-1.0%	$9.0B
Total Liabilities	$716.2B+3.7%	$690.5B+2.4%	$674.5B+2.1%	$660.6B+1.7%	$649.8B-3.6%	$673.8B+4.0%	$648.2B-0.1%	$648.8B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$28.4B-1.9%	$28.9B+4.5%	$27.7B+0.7%	$27.5B+0.2%	$27.4B-11.1%	$30.9B+13.3%	$27.3B-4.5%	$28.5B
Retained Earnings	$44.3B+0.9%	$43.9B+1.0%	$43.4B+0.7%	$43.1B+1.2%	$42.6B+2.1%	$41.8B+2.2%	$40.9B+1.3%	$40.4B

MET Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$17.1B+17.1%	$14.6B+6.4%	$13.7B+5.2%	$13.0B+5.6%	$12.3B+6.1%	$11.6B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$15.6B-35.8%	-$11.5B-12.2%	-$10.2B-291.1%	-$2.6B+76.6%	-$11.2B+39.8%	-$18.6B
Financing Cash Flow	$163.0M+105.2%	-$3.1B-6.5%	-$2.9B+70.4%	-$9.9B-783.5%	-$1.1B-110.5%	$10.7B
Dividends Paid	$1.5B-1.2%	$1.5B-2.5%	$1.6B-2.0%	$1.6B-3.0%	$1.6B-0.6%	$1.7B
Share Buybacks	$2.9B-10.1%	$3.2B+3.4%	$3.1B-6.7%	$3.3B-22.7%	$4.3B+273.8%	$1.2B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$7.1B+98.4%	$3.6B+63.1%	$2.2B-48.7%	$4.3B-7.6%	$4.6B+10.6%	$4.2B+19.5%	$3.5B+49.9%	$2.3B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$4.3B+14.6%	-$5.0B-68.3%	-$3.0B+10.3%	-$3.3B+38.1%	-$5.4B-148.1%	-$2.2B-61.3%	-$1.3B+49.0%	-$2.6B
Financing Cash Flow	-$998.0M-96.5%	-$508.0M-135.1%	$1.4B+558.6%	$220.0M+142.4%	-$519.0M+54.7%	-$1.1B+4.9%	-$1.2B-361.7%	-$261.0M
Dividends Paid	$375.0M-0.8%	$378.0M-1.0%	$382.0M+2.1%	$374.0M-1.1%	$378.0M-1.3%	$383.0M-1.5%	$389.0M+3.2%	$377.0M
Share Buybacks	$460.0M-8.4%	$502.0M-1.6%	$510.0M-63.9%	$1.4B+247.5%	$406.0M-47.5%	$774.0M-9.5%	$855.0M-27.0%	$1.2B

MET Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	8.0%-0.5pp	8.5%-0.1pp	8.6%-0.1pp	8.7%	N/A	N/A
Net Margin	4.4%-1.9pp	6.2%+3.9pp	2.4%-5.3pp	7.7%-2.3pp	10.0%+2.0pp	8.0%
Return on Equity	11.9%-4.2pp	16.1%+10.9pp	5.3%-12.4pp	17.7%+7.5pp	10.2%+2.9pp	7.2%
Return on Assets	0.4%-0.2pp	0.7%+0.4pp	0.2%-0.6pp	0.8%-0.1pp	0.9%+0.2pp	0.7%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	25.22+1.5	23.67+1.8	21.90+0.7	21.18+10.9	10.25+0.6	9.66
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	7.0%-2.5pp	9.5%+1.5pp	8.0%+0.4pp	7.6%-0.4pp	8.0%+0.2pp	7.8%-1.5pp	9.3%+0.6pp	8.7%
Net Margin	3.4%-1.8pp	5.2%+1.0pp	4.2%-0.9pp	5.1%-1.7pp	6.8%-0.5pp	7.3%+2.0pp	5.3%-0.1pp	5.4%
Return on Equity	2.9%-0.2pp	3.1%+0.5pp	2.6%-0.8pp	3.4%-1.2pp	4.6%+0.3pp	4.3%+0.9pp	3.5%+0.4pp	3.0%
Return on Assets	0.1%0.0pp	0.1%+0.0pp	0.1%-0.0pp	0.1%-0.1pp	0.2%0.0pp	0.2%+0.1pp	0.1%+0.0pp	0.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	25.22+1.4	23.86-0.5	24.36+0.3	24.03+0.4	23.67+1.9	21.82-2.0	23.79+1.0	22.74
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

$58.5B

$56.9B

$33.9B

$11.2B

$12.1B

Frequently Asked Questions

What is MetLife's annual revenue?

MetLife (MET) reported $77.1B in total revenue for fiscal year 2025. This represents a 8.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is MetLife's revenue growing?

MetLife (MET) revenue grew by 8.6% year-over-year, from $71.0B to $77.1B in fiscal year 2025.

Is MetLife profitable?

Yes, MetLife (MET) reported a net income of $3.4B in fiscal year 2025, with a net profit margin of 4.4%.

What is MetLife's EBITDA?

MetLife (MET) had EBITDA of $6.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is MetLife's operating margin?

MetLife (MET) had an operating margin of 8.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is MetLife's net profit margin?

MetLife (MET) had a net profit margin of 4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does MetLife pay dividends?

Yes, MetLife (MET) paid $2.25 per share in dividends during fiscal year 2025.

What is MetLife's return on equity (ROE)?

MetLife (MET) has a return on equity of 11.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is MetLife's operating cash flow?

MetLife (MET) generated $17.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are MetLife's total assets?

MetLife (MET) had $745.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Does MetLife buy back shares?

Yes, MetLife (MET) spent $2.9B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does MetLife have outstanding?

MetLife (MET) had 652M shares outstanding as of fiscal year 2025.

What is MetLife's debt-to-equity ratio?

MetLife (MET) had a debt-to-equity ratio of 25.22 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is MetLife's return on assets (ROA)?

MetLife (MET) had a return on assets of 0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is MetLife's Piotroski F-Score?

MetLife (MET) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are MetLife's earnings high quality?

MetLife (MET) has an earnings quality ratio of 5.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can MetLife cover its interest payments?

MetLife (MET) has an interest coverage ratio of 8.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is MetLife?

MetLife (MET) scores 31 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.